Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Galanin Receptor 1 antibody (AA 293-349) (FITC)

This Rabbit Polyclonal antibody specifically detects Galanin Receptor 1 in . It exhibits reactivity toward Human.
Catalog No. ABIN7153433

Quick Overview for Galanin Receptor 1 antibody (AA 293-349) (FITC) (ABIN7153433)

Target

See all Galanin Receptor 1 (GALR1) Antibodies
Galanin Receptor 1 (GALR1)

Reactivity

  • 51
  • 14
  • 10
  • 1
  • 1
Human

Host

  • 53
  • 2
  • 1
Rabbit

Clonality

  • 55
  • 1
Polyclonal

Conjugate

  • 24
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This Galanin Receptor 1 antibody is conjugated to FITC

Application

Please inquire
  • Binding Specificity

    • 6
    • 6
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 293-349

    Cross-Reactivity

    Human

    Purification

    >95%, Protein G purified

    Immunogen

    Recombinant Human Galanin receptor type 1 protein (293-349AA)

    Isotype

    IgG
  • Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C,-80 °C

    Storage Comment

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target

    Galanin Receptor 1 (GALR1)

    Alternative Name

    GALR1

    Background

    Background: Receptor for the hormone galanin. The activity of this receptor is mediated by G proteins that inhibit adenylate cyclase activity.

    Aliases: GALR1 antibody, GALNR antibody, GALNR1Galanin receptor type 1 antibody, GAL1-R antibody, GALR-1 antibody

    UniProt

    P47211

    Pathways

    cAMP Metabolic Process
You are here:
Chat with us!